By identifying that Human Leukocyte Antigens (HLA) play a key role in the genetic origin of autoimmune diseases, RheumaGen is revolutionizing the field of autoimmunity by developing a unique, revolutionary technology that targets the HLA gene itself, using gene editing to turn off the genetic trigger causing the immune system to attack healthy cells.

Back to Portfolio

Latest News

Creating Solutions Together.

Contact Us